NCT06808503

Brief Summary

This study will adapt and evaluate an evidence-based suicide risk screening and follow-up program in two school-based health centers in West Virginia. The suicide screening program is titled the "NIMH Clinical Pathway" and provides tools and procedures for routinely screening adolescents for suicide risk, completing risk assessments, safety planning, lethal means restriction, follow-up referrals, and other disposition planning as appropriate. Investigators aim to do the following:

  1. 1.Gather formative data from providers, parents, and youth to inform ways to adapt and implement the NIMH Clinical Pathway so that it can be effectively implemented in rural, Appalachian School-Based Health Centers (SBHCs).
  2. 2.Gather preliminary data regarding the feasibility, acceptability, and effectiveness of the adapted intervention.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
10mo left

Started Oct 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Oct 2024May 2027

Study Start

First participant enrolled

October 2, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 29, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 5, 2025

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

April 21, 2026

Status Verified

April 1, 2026

Enrollment Period

2.6 years

First QC Date

January 29, 2025

Last Update Submit

April 15, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Number of Patients Screened for Suicidal Risks-Site 1

    Review of patient records for the number of patients that were asked about suicidal thoughts and/or behaviors during their visit. Review will occur for a total of 3 months during the Treatment as Usual Period.

    Total period of 3 Months

  • Number of Patients Screened for Suicidal Risks-Site 2

    Review of patient records for the number of patients that were asked about suicidal thoughts and/or behaviors during their visit. Review will occur for a total of 6 months during the Treatment as Usual Period.

    Total period of 6 Months

  • Number of Patients Reporting Suicidal Risks-Site 1

    Review of patient records for the number of patients that reported having suicidal thoughts and/or behaviors. Review will occur for a total of 12 months during the Intervention Period.

    Total period of 12 Months

  • Number of Patients Reporting Suicidal Risks-Site 2

    Review of patient records for the number of patients that reported having suicidal thoughts and/or behaviors. Review will occur for a total of 12 months during the Interventional Period

    Total period of 12 Months

Secondary Outcomes (54)

  • Safety Planning Rates (Number)- Site 1

    Initial Visit

  • Safety Planning Rates (Number)- Site 1

    3 Month Follow Up Visit

  • Safety Planning Rates (Number)- Site 2

    Initial Visit

  • Safety Planning Rates (Number)- Site 2

    3 Month Follow Up Visit

  • Safety Planning Rates (Percentage)- Site 1

    Initial Visit

  • +49 more secondary outcomes

Study Arms (2)

Treatment As Usual (TAU)

NO INTERVENTION

Review all medical records for patients for the standard of care used at the facility for suicide assessment and risk. Determine if the enrolled patients were assessed and if risks are present.

NIMH Clinical Pathway

ACTIVE COMPARATOR

Implementation of an adapted/tailored version of the NIMH Clinical Pathway, which identifies a workflow and tools for routine suicide risk screening, assessment, safety planning and follow-up.

Behavioral: NIMH Clinical Pathway

Interventions

Complete the implemented workflow and tools for suicide risk screening, assessment, safety planning and follow-up.

NIMH Clinical Pathway

Eligibility Criteria

Age12 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Youth who are receiving services at the school-based health centers to participate
  • Parents must be able to give legal consent for themselves and their children to participate
  • Youth and Parent must be English-speaking
  • Youth must also be able to give signed assent to participate
  • Youth must be cognitively and medically able to participate in study activities

You may not qualify if:

  • Youth in state custody will be excluded from study participation due to challenges related to obtaining legal consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

West Virginia University

Morgantown, West Virginia, 26505, United States

RECRUITING

MeSH Terms

Conditions

Suicide PreventionSuicide

Condition Hierarchy (Ancestors)

Self-Injurious BehaviorBehavioral SymptomsBehavior

Study Officials

  • Mary Christensen, PhD, LICSW

    West Virginia University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mary Christensen, PhD, LICSW

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor and MSW Program Director

Study Record Dates

First Submitted

January 29, 2025

First Posted

February 5, 2025

Study Start

October 2, 2024

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

April 21, 2026

Record last verified: 2026-04

Locations